Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Physical Therapy for Men Undergoing Prostatectomy [NA]
An active, not recruiting clinical trial at Indiana University is evaluating pelvic floor physical therapy for men undergoing prostatectomy …
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Suturing Techniques for Vesico-urethral Anastomosis [NA]
The document notes the completion of a clinical trial evaluating suturing techniques for vesico-urethral anastomosis in prostate cancer surg…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: MR Fingerprinting for Diagnostic of Prostate Cancer
This update describes a completed clinical trial evaluating MR fingerprinting as a diagnostic approach for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy
A completed study evaluating the demographics and outcomes of prostate cancer patients in Italy treated with a 6-month formulation of tripto…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI) [NA]
Clinical trial update indicates a not-yet-recruiting study evaluating the prognostic value of Chemical Exchange Saturation Transfer MRI for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study to Find Maintenance Dose for Periodic Administration of ASP3550 [Phase 2]
Phase 2 study evaluating a maintenance dose for periodic administration of ASP3550 in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer [Phase 3]
Phase 3 trial comparing ASP3550 with Goserelin in prostate cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer [Phase 1, Phase 2]
A clinical trial evaluating Copanlisib in combination with Degarelix for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer
This trial evaluating real-life use of a leuprorelin 5 mg implant in prostate cancer patients has been withdrawn. No results were reported.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007 [NA]
The pivotal BP-007 study of the BioProtect Balloon Implant Balloon System for prostate cancer has completed and posted results as of 2024-10…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer [Phase 1, Phase 2]
The clinical trial evaluated INR101 Injection for PET/CT imaging in healthy male subjects and patients with suspected prostate cancer. The s…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer [NA]
This clinical trial entry outlines the use of artificial intelligence models for precision prediction and treatment of prostate cancer and i…
-
FDA approval · 2024-10-28FDA Approved: ABIRATERONE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Abiraterone acetate under an ANDA.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study of LY3022855 In Participants With Breast or Prostate Cancer [Phase 1]
This Phase 1 study of LY3022855 in breast and prostate cancer has completed, with results posted on 2024-10-28.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence [Phase 2]
A Phase 2 clinical trial is recruiting to evaluate PET imaging for detecting prostate cancer in patients with early PSA recurrence after pro…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
The study investigates whether adding MRI-targeted biopsy to an index-lesion-ipsilateral systematic biopsy improves cancer detection in biop…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008) [Phase 1]
A Phase 1 trial evaluating the absorption, distribution, metabolism, and elimination of Opevesostat (MK-5684) in healthy adult male particip…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer [Phase 1]
Phase 1 study evaluating rh PSMA-7.3 PET/MRI as an imaging agent to detect recurrent prostate cancer and assist in radiotherapy planning; th…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Combination of TURP and Standard Systemic Therapy for MPCa [Phase 2]
Phase 2 clinical trial evaluating the combination of TURP (transurethral resection of the prostate) with standard systemic therapy for metas…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of BZ371A topical for erectile dysfunction in men following radical prostatectomy;…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Adaptive Virtual Consultation Tool to Enhance Education and Understanding in Patients with Prostate Cancer [NA]
A Mayo Clinic-led clinical trial evaluating an adaptive virtual consultation tool to educate and support patients with prostate cancer; the …
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Stockholm3 Validation Study in a Multi-Ethnic Cohort
Update on the Stockholm3 validation study in a multi-ethnic cohort assessing the performance of the Stockholm3 biomarker test for prostate c…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer [Phase 2]
FK-PC101 is being evaluated as adjuvant therapy for high-risk prostate cancer in a Phase 2 trial that is currently recruiting. The study is …
-
EMA approval · 2024-10-18EMA Authorised: Zytiga (abiraterone acetate) — Janssen-Cilag International N.V.
The EMA authorised Zytiga (abiraterone acetate) from Janssen-Cilag International N.V. for prostate cancer under accelerated assessment.
-
FDA approval · 2024-10-18FDA Approved: ORGOVYX — Supplemental Application (Sumitomo Pharma America, Inc.)
The FDA approved a supplemental application for ORGOVYX (relugolix) submitted by Sumitomo Pharma America, Inc., resulting in changes to the …